Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study

OBJECTIVE: Evaluate golimumab in patients with active rheumatoid arthritis (RA) and previous tumour necrosis factor-α (TNF) inhibitor use. METHODS: Patients (n=461) previously receiving ≥1 TNF inhibitor were randomised to subcutaneous injections of placebo, golimumab 50 mg or golimumab 100 mg q4 wee...

Descripción completa

Detalles Bibliográficos
Autores principales: Smolen, Josef S, Kay, Jonathan, Matteson, Eric L, Landewé, Robert, Hsia, Elizabeth C, Xu, Stephen, Zhou, Yiying, Doyle, Mittie K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4173740/
https://www.ncbi.nlm.nih.gov/pubmed/23897769
http://dx.doi.org/10.1136/annrheumdis-2013-203435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4173740/
https://www.ncbi.nlm.nih.gov/pubmed/23897769
http://dx.doi.org/10.1136/annrheumdis-2013-203435

Ejemplares similares